The New York-based law firm is currently evaluating the $14.25 per share cash sale of Utz Brands to Intersnack Group, the merger between Twin Vee PowerCats and USFM Corporation, and the $85.00 per share acquisition of Crinetics Pharmaceuticals by Vertex Pharmaceuticals. According to the firm, these deals may prioritize insider benefits over the interests of ordinary investors.

Halper Sadeh attorneys, led by Daniel Sadeh and Zachary Halper, are seeking to determine if these transactions include provisions that limit superior bids or lack sufficient transparency. The firm is representing shareholders in pursuit of increased consideration or further disclosures. Investors affected by these corporate moves are invited to consult regarding their legal rights on a contingent fee basis.